Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
5,095,892
-
Share change
-
-1,969,460
-
Total reported value
-
$2,736,581
-
Price per share
-
$0.54
-
Number of holders
-
42
-
Value change
-
-$387,096
-
Number of buys
-
14
-
Number of sells
-
10
Institutional Holders of ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) as of Q2 2020
As of 30 Jun 2020,
ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,095,892 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, MORGAN STANLEY, Qube Research & Technologies Ltd, ACADIAN ASSET MANAGEMENT LLC, UBS Group AG, MILLENNIUM MANAGEMENT LLC, and LEVEL FOUR ADVISORY SERVICES, LLC.
This page lists
42
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.